In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...

The author is looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing.

A number of research firms have changed their ratings and price targets for Couchbase (NASDAQ: BASE): 2/27/2025 – Couchbase had its price target lowered by analysts at The Goldman Sachs Group, Inc.

While initial study results suggest Beam's technology can correct alpha-1 antitrypsin deficiency's genetic roots, shares fell ...

Abstract Genome-wide identification of binding profiles for DNA-binding proteins from the limited number of intracellular pathogens in infection ...

The global electrophoresis market is set to witness substantial growth, with its valuation projected to rise from USD 2,268.8 million in 2023 to USD 3,523.50 million by 2033. This expansion reflects a ...

A critically endangered new species of killifish sampled from an ancient forest in Kenya in 2017 and 2018 has been described ...

Audi is reportedly preparing a plug-in hybrid R8 based on the Lamborghini Temerario. With an electrified twin-turbo V8, it ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

Kathy Strong lays a brick honoring Sgt. 1st Class James Moreland atThe Pacific War Memorial by the entrance of Marine Corps Base Hawaii on Tuesday. (Kevin Knodell / ) 1 /4 Kathy Strong lays a brick ...

We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now. In this article, we are going to take a ...

A jury has heard Rajwinder Singh is a "coward" who became the target of a "flawed" police investigation after witnessing ...